Crits-Christoph P, Siqueland L, McCalmont E, Weiss R D, Gastfriend D R, Frank A, Moras K, Barber J P, Blaine J, Thase M E
Department of Psychiatry, University of Pennsylvania, USA.
J Consult Clin Psychol. 2001 Oct;69(5):825-30. doi: 10.1037//0022-006x.69.5.825.
A previous report from the National Institute on Drug Abuse Collaborative Cocaine Treatment Study (P. Crits-Christoph et al., 1999) found relatively superior cocaine and drug use outcomes for individual drug counseling plus group drug counseling compared with other treatments. Using data from that study, the authors examined the relative efficacy of 4 treatments for cocaine dependence on psychosocial and other addiction-associated problems. The 487 patients were randomly assigned to 6 months of treatment with cognitive therapy, supportive-expressive therapy, or individual drug counseling (each with additional group drug counseling), or to group drug counseling alone. Assessments were made at baseline and monthly for 6 months during the acute treatment phase, with follow-up visits at 9 and 12 months. No significant differences between treatments were found on measures of psychiatric symptoms, employment, medical, legal, family-social, interpersonal, or alcohol use problems. The authors concluded that the superiority of individual drug counseling in modifying cocaine use does not extend broadly to other addiction-associated problems.
美国国立药物滥用研究所合作可卡因治疗研究（P. 克里茨 - 克里斯托夫等人，1999年）之前的一份报告发现，与其他治疗方法相比，个体药物咨询加团体药物咨询在可卡因及药物使用结果方面相对更优。作者利用该研究的数据，考察了4种治疗方法对可卡因依赖及心理社会和其他成瘾相关问题的相对疗效。487名患者被随机分配接受为期6个月的认知疗法、支持性表达疗法、个体药物咨询（每种疗法均附加团体药物咨询）或仅接受团体药物咨询治疗。在急性治疗阶段，于基线期及随后6个月每月进行评估，并在9个月和12个月进行随访。在精神症状、就业、医疗、法律、家庭 - 社会、人际或酒精使用问题的测量指标上，各治疗组之间未发现显著差异。作者得出结论，个体药物咨询在改变可卡因使用方面的优势并未广泛延伸至其他成瘾相关问题。
